DUBLIN, Sept. 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ps2k29/benchmarking_the) has announced the addition of the "Benchmarking the Patient Movement - Analysing 11 Therapeutic Areas" report to their offering.
This benchmarking process relies on a system of self-assessment. The findings should therefore be taken as a reflection of the views of participating patient groups, rather than as fact. Nonetheless, the percentages and rankings do measure how patient groups perceive themselves.
The benchmarking process relies on comparing various types of patient groups with others: therapy area with therapy area; country/region with country/region.
The less-successful types of patient groups can learn lessons from the attitudes and activities of their more successful peers.
Analysis:
- 11 therapeutic areas
- 12 countries/regions
- Access to medicines
- Pharma relations
Results compared:
- 2014 with 2012
Therapy areas examined:
- Cancer
- Circulatory
- Diabetes
- Endocrine
- GI
- HIV/AIDS
- Mental health
- Neurological
- Rare diseases
- Respiratory
- Rheumatological
Benchmarking the patient movement is a new robust tool for measuring the performance of patient groups. Launched in 2012 and authenticated by health professional and industry. The 2014 version is available in the form of 14 detailed reports, published August to October 2014.
Key Topics Covered:
- Indicator 1. Business acumen.
- Indicator 2. Communication (via electronic media).
- Indicator 3. Range of services provided.
- Indicator 4. Networking with other healthcare stakeholders.
- Indicator 5. Networking with peer patient groups.
- Indicator 6. Reputation.
- Scale of relationships with pharma, 2012-2014.
- Indicator 7. Impact on national health policy.
- Indicator 8. Perceived hurdles.
- The grid for strategic pointers.
- Profile of respondents
For more information visit http://www.researchandmarkets.com/research/ps2k29/benchmarking_the
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
